Growth Story Still Intact For Applied DNA Sciences Inc. (APDN)

    SBUX Stock
    SBUX Stock

    After grabbing 0.18 million shares, the institutional investor is now in possession of 0.18 million shares of the Industrials Company. The new investment brought the stake of investor firm to 3.64% having worth around $1.85 million. Moreover, The Vanguard Group, Inc. increased its share by 31102.0 to have a control over 0.13 million shares. And BlackRock Fund Advisors raised its holdings to 10731.0 shares by acquiring 83243.0 shares or 1.64% of the stake.

    Applied DNA Sciences Inc. (APDN) concluded trading on 08/27/20 at a closing price of $7.35, with 1.08 million shares of worth about $7.97 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of -20.54% during that period and on Thursday the price saw a loss of about -14.63%. Currently the company’s common shares owned by public are about 4.58M shares, out of which, 4.36M shares are available for trading.

    A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 2 analysts are covering the APDN stock and their offered price forecasts bring an average price target of $21.50. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $22.00 and could fall to a lowest price of $21.00. Analysts also issued an outlook of 2.00 for the Applied DNA Sciences Inc. stock for next 12 months. However, touching the estimated high of $22.00 would mean a gain of 66.59% for the stock.

    According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 20 times over the past 12 months. They bought 3,999,586 shares in 16 of the transactions. In 4 selling transactions, insiders dumped 205,774 shares.

    Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu are the top 3 mutual funds which are holding stakes in Applied DNA Sciences Inc. Vanguard Total Stock Market Index is currently holding 88084.0 shares of worth totaling $0.88 million. The company recently came buying 0.0 shares which brought its stake up to 1.74% of the company’s outstanding shares. Vanguard Extended Market Index Fu bought 2914.0 shares, after which its hold over company’s outstanding shares expand to 0.91%, leaving 46332.0 shares with the mutual fund that have a worth of about $0.46 million. Fidelity Extended Market Index Fu, after buying 20600.0 shares, have now control over 0.41% of the stake in the company. It holds 0.0 shares of worth $0.21 million.

    Applied DNA Sciences Inc. (NASDAQ: APDN) started trading at $8.39, below -$0.22 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $7.35, or with a loss of -14.63%. Stock saw a price change of -20.54% in past 5 days and over the past one month there was a price change of -17.14%. Year-to-date (YTD), APDN shares are showing a performance of 75.42% which decreased to -41.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.52 but also hit the highest price of $19.69 during that period. While comparing its average daily trading volume of 1.27 million shares, we see that about 1.08 million changed hands on the day. The stock is currently trading -23.09% below its 20-day simple moving average (SMA20), while that difference is down -18.57% for SMA50 and it goes to 15.63% higher than SMA200.

    Dillon Hill Capital LLC acquired 0.18 million shares of Applied DNA Sciences Inc. having value of about $1.85 million. Applied DNA Sciences Inc. (NASDAQ: APDN) currently have 4.58M outstanding shares and institutions hold larger chunk of about 12.50% of that. Holding of mutual funds in the company is about 5.62% while other institutional holders and individual stake holders have control over 7.43% and 3.32% of the stake respectively.

    The stock has a current market capitalization of $37.63M and its 3Y-monthly beta is at 1.39. It has posted earnings per share of -$4.07 in the same period. It has Quick Ratio of 4.80 while making debt-to-equity ratio of 0.27. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APDN, volatility over the week remained 8.84% while standing at 9.10% over the month.

    Analysts are in expectations that Applied DNA Sciences Inc. (APDN) stock would likely to be making an EPS of -$0.35 in the current quarter, while forecast for next quarter ESPS is -$0.19 and it is -$0.88 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.45 which is -$0.26 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$2.63 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 38.90% while it is estimated to increase by 68.90% in next year.

    Analysts at 2 brokerage firms have issued recommendations for the Applied DNA Sciences Inc. (APDN)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 2 Wall Street analysts, 2 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

    Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on July 20, 2020 offering a Buy rating for the stock and assigned a target price range of between $18 and $22 to it. Coverage by H.C. Wainwright stated Applied DNA Sciences Inc. (APDN) stock as a Buy in their note to investors on July 02, 2020, suggesting a price target of $18 for the stock. On November 14, 2016, Maxim Group Reiterated their recommendations, while on May 13, 2016, Maxim Group Reiterated their ratings for the stock with a price target of $9. Stock get a Buy rating from Maxim Group on October 08, 2015.


    Please enter your comment!
    Please enter your name here